Shanghai Chest Hospital

This study tests whether combining pembrolizumab (an immunotherapy), bevacizumab (a drug that blocks blood vessel growth), and standard chemotherapy can help people with advanced non-squamous non-small cell lung cancer that has a specific EGFR exon 20 insertion mutation. About 54…

This study tests a new treatment plan for people with advanced esophageal cancer that cannot be removed by surgery. Participants first receive immunotherapy plus chemotherapy, followed by chemoradiation. The goal is to see if this approach improves survival and controls the disea…

This study tests a daily pill called dacomitinib in 30 people with advanced non-small cell lung cancer that has uncommon EGFR gene changes. The goal is to see if the drug can shrink or control tumors. Participants take the drug until their cancer worsens, and researchers track ho…

This study looks at tissue samples from 30 people with esophageal cancer to see how far the cancer cells spread beyond what the surgeon can see. The goal is to better understand these hidden patterns so doctors can remove all the cancer during surgery. Participants are adults wit…